After characterizing the mitochondrial phenotype of ATP5IF1 knockdown AML cells, we tested the hypothesis that ATP5IF1 knockdown would confer resistance to venetoclax in AML cells. This evidence concerns the gene ATP5IF1 and acute myeloid leukemia.